Associated Bacterial Coinfections in COVID-19-Positive Patients.

: The aim of this study was to identify specific rhino- and oropharyngeal microbiological pathogens as well as associated comorbidities that favor SARS-CoV-2 infection and corelate them. : This prospective clinical study enrolled 61 patients (28 COVID-19-positive and 33 controls) who were tested for other comorbidities and co-existence of associated oral pathogenic microbiota. : A total of 247 bacterial isolates were identified in the bacterial cultures in both groups. Viral hepatitis type A was more prevalent in the COVID-19-positive group ( = 0.026), as was the presence of oral candidiasis ( = 0.006). In the control group, a moderate direct relationship was observed between the group G and dermatitis, and strong direct relationships were observed between the group G and external otitis, and dental alveolitis, and and chronic lymphocytic leukemia. In the test group, strong direct relationships were observed between and pulmonary thromboembolism; and autoimmune thyroiditis; post-viral immunosuppression, chronic coronary syndrome, and hypernatremia; group C and rheumatoid polyneuropathy; group G and hyperkalemia, hypothyroidism, secondary anemia, and splenomegaly; and active oral candidiasis and SARS-CoV-2 viral pneumonia. The following relationships were strong, but inverse: group G and acute respiratory failure, and active oral candidiasis and SARS-CoV-2 viral bronchopneumonia. : Briefly, COVID-19-positive patients have the predisposition to build up associated comorbidities and coinfections, which can be the expression of the immune burden that this virus generates to the host.